As clinicians learn how to manage patients most efficiently under a value-based care of delivery, they need to identify patients and risk-stratify those patients, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
As clinicians learn how to manage patients most efficiently under a value-based care of delivery, they need to identify patients and risk-stratify those patients, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
Transcript
What is the artificial intelligence program that Center for Cancer and Blood Disorders is piloting?
This is a very exciting program that we’re piloting and we’re working with an artificial intelligence company called Jvion. The reason that’s important is that as we’re learning how to manage our patients most efficiently under a value-based care of delivery, we really get to a point that we need to identify patients and risk-stratify those patients. If we can identify difficult or problem patients early then maybe we can have interventions that can help with those folks.
We have worked with a company, Jvion, to where we share all of our clinical and practice information but they also have a vast amount of data and information that’s out there, to where for any individual patient that we have, they can explore over 4000 data points around that patient and be able to use those data points to help characterize that patient and potentially identify certain risk factors with those patients. As part of what we’re developed with them is we’ve looked at 7 different vectors and these are just things that we think can negatively impact patients. Working with Jvion, with the artificial intelligence tool that we have, 1 of those vectors is can we predict or identify which of our patients may are going to die within the next 30 days, because if we can identify those patients then maybe there’s interventions that we can plug into those patients to actually prevent that event from occurring or maybe it’s in agreement that those patients indeed are in a state where they are likely to die within the next 30 days and so it allows us to have assurances that we’re appropriately talking to them about palliative care and end-of-life. And so, if we agree with some of the data that Jvion has identifying those patients, then we can incorporate out palliative care team and get those appropriate care plan visits with those patients to help direct their therapy in that way.
There’s many other vectors that we’re looking at so if we can identify people that are at risk of having depression and they’re going to need to be on anti-depressants we can get those people plugged into our psychotherapists if we can identify people that are predicted to have increasing debility, where in the coming months that they might end up in the emergency room or the hospital, then we can incorporate those people into our rehab program or our dietician program in order to optimize their functional capacity in their health and we can look at certain vectors like that in order to help risk-stratify our patients and identify patients that would otherwise we may not have any idea that there’s something underlying that’s going on with them.
Our early data that we have has shown that we have positive impact on those patients and we can utilize, again, the information that we have to get our case managers involved and to get those people appropriately resourced to our ancillary services such as psychotherapy, palliative care, rehab, dietician, integrated therapy, all those things.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More